Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Fox

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Developments in Biological Standardization|January 1, 1975
Group A streptococcal M protein vaccine: protection following immunization via the respiratory tractR H Waldman, J D Lee, S M Polly, et al.
The Journal of Clinical Investigation|August 1, 1973
Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteersE N Fox, R H Waldman, M K Wittner, et al.
The Journal of Infectious Diseases|December 1, 1978
Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A StreptococcusR D'Alessandri, G Plotkin, R M Kluge, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Developments in Biological Standardization|January 1, 1975
Group A streptococcal M protein vaccine: protection following immunization via the respiratory tractR H Waldman, J D Lee, S M Polly, et al.
The Journal of Clinical Investigation|August 1, 1973
Protective study with a group A streptococcal M protein vaccine. Infectivity challenge of human volunteersE N Fox, R H Waldman, M K Wittner, et al.
The Journal of Infectious Diseases|December 1, 1978
Protective studies with group A streptococcal M protein vaccine. III. Challenge of volunteers after systemic or intranasal immunization with Type 3 or Type 12 group A StreptococcusR D'Alessandri, G Plotkin, R M Kluge, et al.
Pageof 2